Drug
Exa Cel
Exa Cel: highest development phase Phase 2/3, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Exa-cel NCT03745287 | Phase 2/3 | Sickle Cell Disease |
Latest
No recent events.
Follow Exa Cel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.